Semaglutide and other GLP-1 receptor agonists have dominated headlines for weight loss effectiveness, but recent patient reports and preliminary research suggest potential neurological benefits
I was like, yeah, sure, whatever
Molecular Structure GLP-3 (Triple Incretin Agonist) Peptide Class: Triple incretin receptor agonist (GLP-1R/GIPR/GCGR) Peptide Length: 39 amino acids (fatty-acid-modified analog) Key Features: Multi-receptor agonism, albumin-binding extension for prolonged activity Form: Lyophilized powder, research-grade Cagrilintide (Long-Acting Amylin Analog) Peptide Class: Long-acting amylin-receptor agonist Peptide Length: 37 amino acids (acylated amylin analog) Key Features: Enhanced stability, prolonged receptor engagement, high amylin-receptor affinity Form: Lyophilized powder, research-grade Both peptides are supplied independently and used in combination for multi-axis metabolic research
They are not just padding
This process is similar to the effects of Bariatric or Gastric bypass surgery
How long does it take for food noise to go away on Ozempic